- 
				
Valganciclovir for the Prevention of CMV After Treatment of Rejection with Anti-Lymphocyte Depleting Antibodies in Kidney Transplant Recipients
 - 
				
Validation of a Hypertension Risk Calculator for Living Kidney Donors
 - 
				
Validation of a Prediction System for Risk of Allograft Loss (iBOX) in Pediatric Kidney Transplant Recipients
 - 
				
Validation of Donor Specific Antibody Characteristics Associated with Deleterious Outcomes: A Single Center Study of 940 Kidney Allograft Recipients
 - 
				
Validation of Shared T Cell Epitope Analysis as a Tool to Detect Preformed Donor-Reactive CD4+ Memory T-helper Cells
 - 
				
Validation of the iBox Surrogate End Point in CNI Free, Belatacept Treated Patients (BENEFIT & BENEFIT-EXT)
 - 
				
Validation of the PROMIS® Medication Adherence Scale Among Kidney Transplant Recipients on Tacrolimus
 - 
				
Validation of Trugraf Gene Expression Profile in a Multicenter Cohort (TOGETHER Study)
 - 
				
Variability In Plasma Donor-derived Cell-free DNA Levels With CLAD More Than 5-years After Lung Transplantation: Pilot Data
 - 
				
Variability of Serum Klotho and FGF-23 Levels During the First Two Years After Kidney Transplantation
 - 
				
Variable Course of Hepatitis A Virus Infection in Solid Organ Transplant Recipients
 - 
				
Variation Exists in Hospital Policies for Donation After Circulatory Death Within a Single Donor Service Area
 - 
				
Variation in Adult Living Donor Liver Transplantation in the United States: Identifying Opportunities for Increased Utilization
 - 
				
Variation in Definition of Death in Donation After Circulatory Death Policies
 - 
				
Variation in Donor Liver Rejection Rates for Donor Quality Among US Transplant Centers
 - 
				
Variation in Immunosuppressive Regimen in Children Receiving Liver Transplants: An Analysis of the UNOS Database
 - 
				
Vascularized Tracheal Transplantation; A One Year Update
 - 
				
VCA Waiting List and Transplant Trends and Challenges in the US
 - 
				
Ventricular Modeling Following Bariatric Surgery Decreases Need for Heart Transplantation
 - 
				
Very Low Frequency of Pathological Findings in One-Year Protocol Biopsies of Low-Risk Kidney Transplant Recipients – Results from the Nordic Protocol Biopsy Study
 - 
				
Very Small Pediatric Donors May Help Address the Sex Disparity in Access to Kidney Transplantation
 - 
				
Viral-Specific Cytotoxic T-Cell Responses in Hla-Sensitized Kidney Transplant Patients Maintained on Everolimus and Low Dose Tacrolimus
 - 
				
Vitamin D Deficiency in Liver Transplant Recipients
 - 
				
Vitamin D Status and Sars-cov-2 Infection in a Cohort of Renal Transplanted Patients
 - 
				
Vitrification of Pancreatic Islets and Transplantation
 - 
				
Voxelated Bioprinting of Mechanically Robust Multiscale Porous Scaffolds for Islet Transplantation
 
2022 American Transplant Congress
June 4-8, 2022 in Boston, MA
The ATC program is built in the Eastern Time Zone.
